UCI Hematopoietic Stem Cell Transplant and Cellular Therapy Program
Locations
Transplant Summary
From January 1, 2022 to December 31st, 2023
Program type: Adult
13
Marrow
49
PBSC
0
Cord Blood
64
Autologous*
*PBSC or marrow
Overview
UCI Health Chao Family Comprehensive Cancer Center is expanding treatment options for cancers of the blood or lymph systems with the launch of Orange County's first adult bone marrow transplant program.
Patients with diseases such as leukemia, lymphoma and multiple myeloma now can benefit from life-saving infusions of healthy blood stem cells. Called the Hematopoietic Stem Cell Transplant and Cellular Therapy Program, it also opens the way to emerging immunotherapy options, such as CAR T-cell therapy, for patients with many types of cancer.
Our internationally recognized stem-cell transplant experts also provide full pre-and-post transplant follow-up, allowing patients to receive high-quality, seamless care close to home. And as Orange County's only National Cancer Institute-designated comprehensive cancer center, our patients also have access to early-phase clinical trials and advanced therapies before they are available elsewhere.This center has been performing allogeneic transplants since 2020 and has been an NMDP transplant center since December 2023.
Attending physicians
Adult - Stephan Ciurea, Deepa Jeyakumar, Piyanuch Kongtim, Richard Van EttenTransplants performed
Marrow/PBSC onlyCord blood transplants
Not performedOther programs and services
UCI Health also has a growing number of cellular therapy clinical trials for patients with hematological malignancies and solid tumors. Among the most promising is CAR T-cell therapy, an innovative treatment for certain blood cancers that is also being studied as a treatment for other cancer types.Patient survival information for this center
This center's actual 1-year survival results are similar to the expected rate for this center*.The survival information we have for this center includes ONLY:- Patients who had their FIRST ALLOGENEIC transplant (cells from a related or unrelated donor/cord blood) during 2020, 2021, 2022 and
- Who had their transplant at a U.S. transplant center, and
- Who had follow-up information provided by the transplant center for analysis
For this center, we have survival information for 44 patients.The actual 1-year survival of these patients is 75%.Compared to similar patients transplanted at all centers in the U.S., we expect that the 1-year survival for patients at this center to be in a range between 63.6% and 87.5%.For help with understanding these statistics, please see Understanding Transplant Outcomes.For overall survival for all patients transplanted with a specific disease, please see U.S. Patient Survival report (Opens in a new tab) at bloodcell.transplant.hrsa.gov.* The expected survival rate for a transplant center can be below, similar to, or above the range listed. This is based on comparing patient survival at all centers that treated patients with similar diseases.
The survival rate cannot tell how you will do with your transplant. Talk to your doctor to understand your prognosis or the likely course of your disease.
Total adult transplants
126
Transplants reported by the centers (from January 1, 2022 to December 31, 2023)
Marrow PBSC Cord blood Total AllogeneicRelated donorMarrow12PBSC44Cord blood0Total56Unrelated donorMarrow1PBSC5Cord blood0Total6Total allogeneicMarrow13PBSC49Cord blood0Total62AutologousMarrowBoth marrow & PBSC 64PBSC—Cord blood—Total64Total combinedMarrowBoth marrow & PBSC 126PBSC—Cord blood0Total126All Diseases
Number of transplants by age reported from January 1, 2022 to December 31st, 2023(includes marrow, PBSC and cord blood)
0-18 19-44 45-64 65+ Total Related 0-18019-442145-642365+13Total57Unrelated 0-18019-44145-64465+1Total6Autologous 0-18019-441845-642865+18Total64Total 0-18019-444045-645565+32Total127Treatments may be similar for diseases within a group. It might be helpful to look at centers that have done transplants for a specific disease and centers that have done transplants for any corresponding broad disease categories.
Centers are not required to report autologous transplants so the numbers might be incomplete.
More information about transplants can be found:
- U.S. Transplant Data by Center (Opens in a new tab) report at blood cell.transplant.hrsa.gov
- List of diseases
Transplant center resources
If you have questions about costs and financial services at this center, please call the transplant center’s direct phone number.NMDP patient navigators
Patient navigators can answer your questions about choosing a transplant center and provide support and education to help you throughout your transplant journey.
- Inside the United States: 1 (888) 999-6743
- Outside the United States: 1 (763) 406-3410. (Long distance or international charges may apply.)
Email: patientinfo@nmdp.org
More resources
- Choosing a transplant center
- Preparing for transplant
- Learn about transplant outcomes and treatment decisions (Opens in a new tab)
- Support and resources (including non-English materials)
- U.S. Transplant Data by Center (Opens in a new tab) at blood cell.transplant.hrsa.gov
UCI Hematopoietic Stem Cell Transplantation and Cellular Therapy Program
101 The City Drive Orange, CA 92868 Phone:714-456-8000 For more information about this program: https://www.ucihealth.org/medical-services/bone-marrow-transplant (Opens in a new tab)Staff
Program Director:Dr. Stefan Ciurea, MDProgram Coordinator:Kathleen Majeski MSN/RN, Christina Golly, BSN/RNMedical Specialties in Program
Allergy/immunology, cardiology, complementary and alternative medicine, dermatology, endocrinology, gastroenterology, general surgery, gynecology, hematology, hepatology, infectious disease, nephrology, neurology, oncology, ophthalmology/optometry, orthopedics, otolaryngology, palliative care, psychiatry/psychology, pulmonology, rheumatology, telemedicine, urology.Medical Services Offered
Chronic GVHD management, fertility counseling, reproductive health, financial counseling, genetic counseling, nutrition/dietetics, occupational therapy, pain management, physical therapy and rehabilitation, sexual health, social services, vaccinations.Telemedicine services are available.Patient Eligibility
Adults- Allogeneic and Autologous transplant recipients
- Adults: 100 days after transplant.
- Adults (over age 18)
- Will provide care to adult patients who underwent transplant as a child
- Does accept patients who were transplanted at another hospital